Email: [email protected]
Nancy M. Cappello, Ph.D. led an illustrious career as a Teacher, Building and Central Office Administrator, State Department of Education Consultant and Chief, and an Adjunct Lecturer at the University of Connecticut. Her advocacy, on behalf of students with disabilities, afforded her many opportunities for local, state and national advocacy efforts, conducting presentations across the country in addition to due process mediation sessions between families and school district personnel. She has relied on these skills when diagnosed with advanced stage breast cancer which catapulted her to an unpaved and bumpy road less traveled - patient health care advocacy and non profit development.
Please browse the website further to learn about dense breast tissue, use the available resources, read and share stories and consider making a donation to help expose this BEST-KEPT SECRET about the limitations of mammography alone to detect cancer in women with dense breast tissues.
Are You Dense, Inc. is a 501(c)(3) public charity. IRS Tax ID 26-3643216. All donations are tax-deductible as allowed by law.
Breast density is one of the strongest predictors of the failure of mammography screening to detect cancer.
Two-thirds of pre-menopausal women and 1/4 of post menopausal women have dense breast tissue.
Adding more sensitive tests to mammography significantly increase detection of invasive cancers that are small and node negative.
Cancer turns up five times more often in women with extremely dense breasts than those with the most fatty tissue.
While a mammogram detects 98% of cancers in women with fatty breasts, it finds only 48% in women with the densest breasts.
A woman at average risk and a woman at high risk have an EQUAL chance of having their cancer masked by mammogram.
Women with dense breasts who had breast cancer have a four times higher risk of recurrence than women with less-dense breasts.
There are too many women who are unaware of their breast density, believe their “Happy Gram” when it reports no significant findings and are at risk of receiving a later stage cancer diagnosis.